These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron KS; Benseler S; Berard R; Broderick L; Dedeoglu F; Diebold M; Durrant KL; Ferguson P; Foell D; Hausmann J; Jones OY; Kastner DL; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman H; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E Ann Rheum Dis; 2022 Jul; 81(7):907-921. PubMed ID: 35623638 [TBL] [Abstract][Full Text] [Related]
30. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. Sanchez GAM; Reinhardt A; Ramsey S; Wittkowski H; Hashkes PJ; Berkun Y; Schalm S; Murias S; Dare JA; Brown D; Stone DL; Gao L; Klausmeier T; Foell D; de Jesus AA; Chapelle DC; Kim H; Dill S; Colbert RA; Failla L; Kost B; O'Brien M; Reynolds JC; Folio LR; Calvo KR; Paul SM; Weir N; Brofferio A; Soldatos A; Biancotto A; Cowen EW; Digiovanna JJ; Gadina M; Lipton AJ; Hadigan C; Holland SM; Fontana J; Alawad AS; Brown RJ; Rother KI; Heller T; Brooks KM; Kumar P; Brooks SR; Waldman M; Singh HK; Nickeleit V; Silk M; Prakash A; Janes JM; Ozen S; Wakim PG; Brogan PA; Macias WL; Goldbach-Mansky R J Clin Invest; 2018 Jul; 128(7):3041-3052. PubMed ID: 29649002 [TBL] [Abstract][Full Text] [Related]
31. Treatment of autoinflammatory syndromes. Gattorno M; Martini A Curr Opin Pediatr; 2010 Dec; 22(6):771-8. PubMed ID: 20966753 [TBL] [Abstract][Full Text] [Related]
32. [Pathogenesis and Clinical Examination of Autoinflammatory Syndrome]. Ida H Rinsho Byori; 2015 Oct; 63(10):1207-12. PubMed ID: 26897858 [TBL] [Abstract][Full Text] [Related]
33. Monogenic autoinflammatory disorders: beyond the periodic fever. Moghaddas F Intern Med J; 2020 Feb; 50(2):151-164. PubMed ID: 31260149 [TBL] [Abstract][Full Text] [Related]
34. Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Rigante D Med Sci Monit; 2009 Aug; 15(8):RA179-87. PubMed ID: 19644432 [TBL] [Abstract][Full Text] [Related]
35. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist. Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron K; Benseler S; Berard RA; Broderick L; Dedeoglu F; Diebold M; Durrant K; Ferguson P; Foell D; Hausmann JS; Jones OY; Kastner D; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman HM; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E Arthritis Rheumatol; 2022 Jul; 74(7):1102-1121. PubMed ID: 35621220 [TBL] [Abstract][Full Text] [Related]
36. Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens. Cattalini M; Soliani M; Lopalco G; Rigante D; Cantarini L Intern Emerg Med; 2016 Sep; 11(6):781-91. PubMed ID: 27221072 [TBL] [Abstract][Full Text] [Related]
38. IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives. Malcova H; Strizova Z; Milota T; Striz I; Sediva A; Cebecauerova D; Horvath R Front Immunol; 2020; 11():619257. PubMed ID: 33603750 [TBL] [Abstract][Full Text] [Related]